Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 11:13 am Sale | 2025-10-31 | 13G | Hillenbrand, Inc. HI | FMR LLC | 95,321 0.100% | -4,514,334 (-97.93%) | Filing History |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | Franco-Nevada Corporation FNV | FMR LLC | 19,615,845 10.200% | 1,833,774 (+10.31%) | Filing History |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | CytomX Therapeutics, Inc. CTMX | FMR LLC | 20,519,967 12.400% | 5,123,767 (+33.28%) | Filing History |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | TransAlta Corporation TAC | FMR LLC | 32,248,431 10.900% | 9,627,411 (+42.56%) | Filing History |
| 2025-11-07 11:13 am Sale | 2025-10-31 | 13G | Astria Therapeutics, Inc. ATXS | FMR LLC | 1,251,766 2.200% | -3,902,148 (-75.71%) | Filing History |
| 2025-11-07 11:13 am Sale | 2025-10-31 | 13G | Avidity Biosciences, Inc. RNA | FMR LLC | 2,958,712 2.100% | -18,589,271 (-86.27%) | Filing History |
| 2025-11-07 11:13 am Sale | 2025-10-31 | 13G | Pulmonx Corporation LUNG | FMR LLC | 70,825 0.200% | -2,109,168 (-96.75%) | Filing History |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | CAMP4 Therapeutics Corporation CAMP | FMR LLC | 3,145,663 6.700% | 122,229 (+4.04%) | Filing History |
| 2025-11-07 11:13 am Sale | 2025-10-31 | 13G | Nurix Therapeutics, Inc. NRIX | FMR LLC | 4,159,940 4.100% | -4,627,597 (-52.66%) | Filing History |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | LENZ Therapeutics, Inc. LENZ | FMR LLC | 4,278,244 15.000% | 4,278,244 (New Position) | Filing History |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | Coherent, Inc. COHR | FMR LLC | 17,142,548 10.900% | 4,291,338 (+33.39%) | Filing History |
| 2025-11-07 11:13 am Sale | 2025-10-31 | 13G | Perspective Therapeutics, Inc. CATX | FMR LLC | 6,063,330 8.200% | -3,432,895 (-36.15%) | Filing History |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | FMR LLC | 8,499,100 14.800% | 8,499,100 (New Position) | Filing History |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | Lumentum Holdings Inc. LITE | FMR LLC | 7,423,608 10.400% | 1,234,740 (+19.95%) | Filing History |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | Vestis Corporation VSTS | FMR LLC | 13,523,997 10.300% | 3,913,350 (+40.72%) | Filing History |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | LifeStance Health Group, Inc. LFST | FMR LLC | 39,249,054 10.100% | 404,298 (+1.04%) | Filing History |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | Knight-Swift Transportation Holdings Inc. KNX | FMR LLC | 16,304,678 10.000% | 3,414,545 (+26.49%) | Filing History |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | Vor Biopharma Inc. VOR | FMR LLC | 788,447 11.500% | 788,447 (New Position) | Filing History |
| 2025-11-07 11:13 am Purchase | 2025-10-31 | 13G | Westinghouse Air Brake Technologies Corporation WAB | FMR LLC | 17,365,916 10.200% | 1,074,196 (+6.59%) | Filing History |
| 2025-11-07 11:12 am Purchase | 2025-10-31 | 13G | iShares MSCI Eurozone ETF EZU | FMR LLC | 13,920,399 10.300% | 3,187,526 (+29.70%) | Filing History |